Encoded Therapeutics Stock

encoded.comHealthcareFounded: 2014Funding to Date: $670.89MM

Encoded Therapeutics is a biotechnology company advancing precision medicines for a broad range of genetic disorders.

Register for Details

For more details on financing and valuation for Encoded Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Encoded Therapeutics.

Register Today

Team

Management Team

Kartik Ramamoorthi Ph.D
Co-Founder, Board Member & Chief Executive Officer
David Oberkofler JD
Chief Operating Officer
Stephanie Tagliatela Ph.D
Co-Founder, Chief Scientific Officer & Board Member

Board Members

Karan Takhar
Matrix Capital Management
Bryan Roberts Ph.D
Kartik Ramamoorthi Ph.D
Sean Nolan
John Stuelpnagel
Robert Nelsen
ARCH Venture Partners
Stephanie Tagliatela Ph.D

Other companies like Encoded Therapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$334.19MM

News

SOUTH SAN FRANCISCO, Calif., June 26, 2019 /PRNewswire/ -- Encoded Therapeutics, Inc. (Encoded), a precision gene therapy company, today announced a $104...
Encoded Therapeutics, Inc., a South San Francisco, Calif.-based precision gene therapy company, raised $104m in Series C financing